Lawrence E Doolin

Title: The Innovations of Lawrence E Doolin

Introduction

Lawrence E Doolin is a notable inventor based in Indianapolis, IN (US). He has made significant contributions to the field of antibiotics, particularly with his innovative work on glycopeptide antibiotics. With a total of 2 patents to his name, Doolin's inventions have the potential to impact both human health and animal husbandry.

Latest Patents

One of Doolin's latest patents is for the A80407 antibiotics, which are new glycopeptide antibiotics comprising A80407A and A80407B. These antibiotics are produced by Kibdelosporangium philippinensis strains NRRL 18198 and NRRL 18199, or A80407-producing mutants of these strains. The A80407 antibiotics exhibit excellent activity against Gram-positive bacteria, enhance feed-utilization efficiency in monogastric and ruminant animals, and improve weight gains in animals.

Career Highlights

Doolin is currently associated with Eli Lilly and Company, where he continues to innovate and develop new pharmaceutical solutions. His work has been instrumental in advancing antibiotic treatments and improving agricultural practices.

Collaborations

Throughout his career, Doolin has collaborated with esteemed colleagues such as Richard M Gale and Otis W Godfrey. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Lawrence E Doolin's contributions to the field of antibiotics through his patents and collaborations highlight his role as a significant inventor. His work not only addresses critical health issues but also enhances agricultural efficiency, showcasing the importance of innovation in multiple sectors.